Editor:
Cristophe Nicot: Kansas University Medical Center, USA
Molecular Cancer is calling for submissions to our Collection on 'Phase 2 and 3 studies.' Topics of interest include original reports on human clinical trials phase 2 and phase 3 as well as reviews of recently reported clinical trials.
Molecular Cancer is calling for submissions to our Collection on 'Phase 2 and 3 studies.'
Topics of interest include original reports on human clinical trials phase 2 and phase 3 as well as reviews of recently reported clinical trials. The collection also invites authors to submit research article or correspondence related to clinical biomarkers of disease progression and/or resistance to commonly used therapies. The collection is open to submissions till 15th October 2023.
Image credit: © vitanovski / Stock.adobe.com
There are currently no articles in this collection.
This Collection welcomes submission of Research Articles, Reviews, and Correspondence. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Phase 2 and 3 studies" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editor has no competing interests with the submissions which are handled through the peer review process. The peer review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.